ArticleBMC geriatrics2025
Association of frailty and malnutrition with pneumonia severity in PCV-13 vaccinated older adults: a single-centre experience.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPneumonia remains a leading cause of morbidity and mortality in older adults, particularly due to the age-related decline in immune function. The aim of this study was to evaluate the association between frailty, malnutrition, and the severity of pneumonia in older adults who received the 13-valent pneumococcal conjugate vaccine (PCV13).
methodsA retrospective analysis was made of 407 geriatric outpatients aged over 65 years who had received PCV13. Clinical and radiological data were collected from electronic health records and verified via telephone interviews. The primary outcomes were incidence and severity of pneumonia (mild vs. severe), hospitalization, mortality, and antibiotic use within one year following vaccination. Pneumonia severity was classified according to established criteria in the literature.
resultsOf the 407 patients evaluated (mean age 73.3 ± 6.3 years; range 65–91 years; 62.9% female), 50 (12.2%) developed pneumonia within one year after PCV13 vaccination. Pneumonia was more common in patients with diabetes mellitus (p = 0.003) and chronic obstructive pulmonary disease (p < 0.001). Severe pneumonia was significantly more prevalent among frail individuals (p = 0.006). Compared to patients with mild pneumonia, those with severe pneumonia had higher Clinical Frailty Scale scores and prolonged chair stand test durations (p = 0.002 and p = 0.031, respectively). After adjusting for age, sex, and frailty, malnutrition emerged as an independent risk factor for severe pneumonia (OR: 11.9, 95% CI: 1.592–89.285, p = 0.016).
conclusionThe findings of this study indicate that malnutrition and frailty are independent risk factors for severe pneumonia diagnosed within a year of PCV13 vaccination in older adults. Consequently, comprehensive geriatric assessment and targeted interventions beyond vaccination are essential to reduce pneumonia risk in frail or malnourished older populations.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.